London, United Kingdom

Gregory Alan Stoloff

This inventor holds 43 USPTO granted patents and 12 published patent applications, plus 5 CIPO patents and 11 EPO patents, primarily in Chronic Inflammation Treatment. Top assignees: Infirst Healthcare Limited, Peptcell Limited, Tangent Reprofiling Limited. Active years: 2013-2026.

USPTO Granted Patents = 43 

% Patents Active = 90.7

 

 

Average Co-Inventor Count = 3.2

ph-index = 12

Forward Citations = 553(Granted Patents)


Company Filing History:


Years Active: 2013-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Chronic Inflammation
Cancer Drugs
Cardiovascular Diseases
Peptide Sequences
Influenza Peptides
NSAIDs
Androgen Synthesis Modulators
HIV Compositions
Immunogenic Peptides
Chagas Antigens
Antibodies
Pharmaceutical Compounds
43 patents (USPTO):Explore Patents

Title: Gregory Alan Stoloff - Innovative Inventor from London, GB

Introduction: Gregory Alan Stoloff is a renowned inventor based in London, GB, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Gregory Alan Stoloff holds several patents in the areas of technology, healthcare, and sustainable energy, showcasing his diverse range of interests and expertise.

Career Highlights: With a career spanning over two decades, Gregory Alan Stoloff has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have made a significant impact on society.

Collaborations: Throughout his career, Gregory Alan Stoloff has collaborated with leading research institutions, universities, and companies worldwide, fostering a culture of innovation and knowledge sharing.

Conclusion: Gregory Alan Stoloff's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…